FGF21 and Abdominal obesity: In stark contrast, FGF21 LKO completely reversed (p < 0.01) high circulating corticosterone but not high FSH in OVX mice (Figure 5A,B), suggesting the abrogative effect of FGF21 LKO on OVX-induced central obesity was realized via reversing corticosterone production but not FSH in females.